WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
On May 14th, MENGNIU DAIRY (02319) spent HK$362,300 to repurchase 21,000 shares.
Standard Chartered (02888) spent 14.9973 million on May 13 to repurchase 801,200 shares.
COUNTRY GARDEN (02007) issued 165 million shares of zero-coupon mandatory convertible bonds that were converted.
On May 14th, MENGNIU DAIRY (02319) spent HK$362,300 to repurchase 21,000 shares.
Standard Chartered (02888) spent 14.9973 million on May 13 to repurchase 801,200 shares.
COUNTRY GARDEN (02007) issued 165 million shares of zero-coupon mandatory convertible bonds that were converted.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
